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Abstract
MicroRNAs have emerged as important regulators of smooth muscle phenotype and may play important roles in
pathogenesis of various smooth muscle related disease states. The aim of this study was to investigate the role of miRNAs
for urinary bladder function. We used an inducible and smooth muscle specific Dicer knockout (KO) mouse which resulted in
significantly reduced levels of miRNAs, including miR-145, miR-143, miR-22, miR125b-5p and miR-27a, from detrusor
preparations without mucosa. Deletion of Dicer resulted in a disturbed micturition pattern in vivo and reduced
depolarization-induced pressure development in the isolated detrusor. Furthermore, electrical field stimulation revealed
a decreased cholinergic but maintained purinergic component of neurogenic activation in Dicer KO bladder strips. The
ultrastructure of detrusor smooth muscle cells was well maintained, and the density of nerve terminals was similar. Western
blotting demonstrated reduced contents of calponin and desmin. Smooth muscle a-actin, SM22a and myocardin were
unchanged. Activation of strips with exogenous agonists showed that depolarization-induced contraction was preferentially
reduced; ATP- and calyculin A-induced contractions were unchanged. Quantitative real time PCR and western blotting
demonstrated reduced expression of Cav1.2 (Cacna1c). It is concluded that smooth muscle miRNAs play an important role
for detrusor contractility and voiding pattern of unrestrained mice. This is mediated in part via effects on expression of
smooth muscle differentiation markers and L-type Ca
2+ channels in the detrusor.
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Introduction
Emptying of the urinary bladder depends on coordinated
contraction of the detrusor and relaxation of the urethra [1,2].
Contraction follows the release of neurotransmitters from motor
nerves that are dispersed in the muscle bundles [3]. This results in
a rapid elevation of the sarcoplasmic Ca
2+ concentration,
activation of myosin light chain kinase, phosphorylation of myosin,
and, after a brief delay, force development [4]. Acetylcholine is
central among the transmitters released from neural varicosities in
the detrusor, and the muscarinic Gq-coupled M3 receptor is
primarily responsible for cholinergic detrusor activation [5]. M2
receptors also contribute by inhibiting the formation of cyclic
AMP [6]. In addition to muscarinic mechanisms, purinergic
signalling plays a role [7], and the relative contribution of
purinergic versus cholinergic excitation varies between species and
in pathological situations. In humans, for example, the relative size
of the muscarinic component of neurogenic activation decreases
with age and in bladder disturbances [7,8,9,10]; this so called
‘‘atropine resistance’’ is accompanied by an increase in the relative
dependence on purinergic activation.
Recently, microRNAs have emerged as promising targets for
therapeutic intervention in various disease states [11–14]. miRNAs
are short non-coding RNAs that regulate protein expression and
cellular function [15]. Mature miRNAs are generated from
cleavage of pre-miRNAs by the endonuclease Dicer and are then
incorporated into the RNA-induced silencing complex, which
mediates degradation or translational repression/activation of the
target mRNA. MiRNAs were recently identified to have an
important role for vascular smooth muscle development and
function by regulating phenotypic modulation, contractile function
and neointimal hyperplasia [16–23]. Dramatic effects of miRNA
depletion on smooth muscle differentiation and remodelling has
also been reported for gastrointestinal smooth muscle [24]. In
urinary bladder, a role of miRNAs in cancer has been identified
[25]. However, the importance of miRNAs for detrusor smooth
muscle function and phenotype modulation is unknown.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35882In this study we have used an inducible and smooth muscle
specific Dicer knockout (KO) mouse to investigate the role of
miRNAs for bladder function. We found that loss of miRNAs
resulted in a decreased contractile function in response to
depolarization, which was associated with reduced expression of
contractile marker proteins and L-type Ca
2+ channels. Our
findings also imply that miRNAs in smooth muscle may play
a role for cholinergic neuro-effector transmission in the urinary
bladder.
Materials and Methods
Animals
Adult mice with inducible and smooth muscle cell specific
inactivation of Dicer were generated as described previously [26].
At the age of 4 weeks, male SMMHC-CreERT2/Dicer
flox/flox
(SM-Dicer KO) mice were treated with intraperitoneal injections
of 0.1 ml Tamoxifen (50 mg/kg/day) or vehicle (1:10 EtOH in
sunflower oil) for 5 consecutive days. Vehicle treated male
littermate mice were used as controls. Experiments were
performed 5 or 10 weeks post tamoxifen injections. Mice were
on a mixed C57Bl/6;129 background and all animal experiments
were approved by the Lund/Malmo ¨ Ethics Committee (M167-
09).
MiRNA Arrays and Quantitative RT-PCR
Mice were sacrificed by increasing CO2 and whole bladders
were excised and cleaned in HEPES buffered Krebs solution
(nominally Ca
2+-free). Bladders were cut open from the urethra
and pinned to the bottom of Sylgard-covered dissection dishes
containing physiological buffer. The mucosa was removed by
pulling using fine forceps in combination with sharp micro-
dissection. Following freezing in liquid N2, isolation of mRNA and
miRNA from six pooled control and Dicer KO bladders without
mucosa was performed using miRNeasy kit and RNeasy MinElute
Cleanup Kit (Qiagen) according to the manufacturer’s recom-
mendations. Whole genome, qPCR based, miRNA arrays (RT2
miRNA PCR Array mouse, #MAM-200C-2, SA Biosciences)
were used according to the manufacturer’s instructions. Individual
miRNAs and mRNAs were analyzed using miScript primer assays
(Qiagen) and QuantiTect Primer assays (Qiagen), respectively.
Voiding Patterns of Freely Moving Mice
Mice were housed individually in standard cages and 24 h urine
output was collected on filter papers covering the whole cage area
[27]. Papers were photographed under ultraviolet light. Spots were
analyzed by blinded counting of the total number of spots, the
number of spots bordering the edge of the filter paper (edge), and
those that did not touch the edge of the paper (center).
Isolated Bladder Preparation
The ureters of isolated bladders were ligated and the bladder
was catheterized via the urethra. The catheter was connected to
a pressure transducer (Living Systems Instrumentation) and
a peristaltic pump. The bladder was then positioned in a 50 ml
water jacketed bath containing aerated HEPES buffered Krebs
solution (2.5 mM Ca
2+,3 7 uC). Intravesicular pressure was
continuously recorded using the PM4 perfusion pressure monitor
(Living Systems Instrumentation) and WinDaq waveform re-
cording software (Dataq Instruments). Buffer was injected through
the catheter (50, 100 and 200 ml) in a stepwise fashion. After
stabilization of passive pressure at each volume, 60 mM K
+
(obtained by exchange of NaCl for KCl) was added to the bathing
solution. Active pressure was maintained for 5 min and integrated
over the entire stimulation period.
Strip Preparations and Length-tension Relationship
Force measurements were done essentially as described [28]
using equatorial bladder strips without mucosa. In brief, prepara-
tions were mounted in myographs with open organ baths (three
610 M, Danish MyoTechnology, Aarhus, Denmark) filled with
aerated HEPES buffered Krebs solution (2.5 mM Ca
2+,3 7 uC).
Length was systematically increased and strips were contracted
with 60 mM K
+ at each length followed by relaxation in Ca
2+-free
HEPES buffered Krebs solution. The preparations were then
stretched to a new length and allowed to equilibrate in Ca
2+-
containing buffer prior to contraction with 60 mM K
+.
Electrical field stimulation, carbachol concentration-response
relationships, and ATP responses were recorded at the optimal
length for force development (L0). After each experiment the
lengths and weights of the individual preparations were de-
termined to allow for calculation of stress (force per cross-sectional
area).
Electrical Field Stimulation
Bladder smooth muscle strips without mucosa were prepared
and mounted as described [29]. Full frequency response curves
(5 s activation, pulse duration 0.5 ms, at 2 min intervals) were
generated in control conditions, in the presence of scopolamine
(1 mM), and after desensitization of purine receptors using a,b-
methylene-ATP (10 mM) in the continued presence of scopol-
amine [28]. Each experiment was started and ended by
depolarizing the smooth muscle with 125 mM KCl.
Electron Microscopy
All bladders were filled with 0.3 ml saline through the urethra
[21]. Processing for fixation and electron microscopy was
performed as described [28]. 100 digital micrographs at three
levels of magnification (10, 30, and 60 K) were acquired (600 in
total) and analyzed using ImageJ (NIH, Bethesda, MD, USA).
Western Blotting
Detrusor muscle homogenates were prepared from control and
Dicer KO bladders as described previously [28]. Briefly, the
samples were frozen in liquid N2, dissolved in Laemmli buffer
containing phosphatase and protease inhibitor cocktails (Bio-Rad).
Following determination of protein concentration, equal amounts
of protein were loaded on TGX Criterion gels (Biorad). Proteins
were then transferred using either wet transfer over-night or semi-
dry transfer for 10 min using the Trans-Blot Turbo system
(Biorad). Proteins were detected using commercially available
primary antibodies: Desmin (Cell Signaling, 1:1000), Calponin
(1:1000) and SM22 (1:2000) and Myocardin (Abcam, 1:500), a-
actin (Sigma, 1:1000), HSP90 (BD Transduction labs., 1:1000),
Ca
2+/calmodulin-dependent protein kinase (CamKIId, R&D
Systems, 1:500), and Cav1.2 (Alomone labs, 1:500). HRP-
conjugated or fluorescently labeled DyLight800 and DyLight680
secondary antibodies (Cell Signaling, 1:5000) were used and
images were acquired using the LI-COR Odyssey Fc instrument
(LI-COR Biosciences).
Statistical Analysis
All data are presented as means 6 SEM and single comparisons
between two groups were performed using student’s t-test.
Multiple comparisons were performed using ANOVA followed
MicroRNAs Control Detrusor Function
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*=p,0.05, **=p,0.01, ***=p,0.001.
Results
Deletion of Dicer Results in a General Loss of miRNAs in
the Bladder
To assess the effect of smooth muscle specific Dicer knockout
(KO) on the miRNA expression pattern in the urinary bladder,
miRNA arrays were run using pooled samples from control and
KO bladders without mucosa. MiR-145, miR-22, miR-125b-5p,
miR-27a and miR-1 appeared to be most highly expressed in the
bladder muscle layer, and their knockdown level ranged between
68 and 99% (Table S1). We chose 11 highly expressed miRNAs
from the array for validation by quantitative RT-PCR. MiR-143
was not on the array but was included because it is generated
together with miR-145 from a bicistronic transcript [16]. MiR-451
was included as a negative control as it is known to be generated in
a Dicer independent manner [30,31]. With the exception for miR-
451, Dicer deletion resulted in significant reduction of all of these
miRNAs (Figure 1A, 10 weeks post tamoxifen). Taken together,
this demonstrates efficient knockdown of miRNAs in detrusor
smooth muscle following deletion of Dicer.
Loss of miRNAs did not significantly affect bladder weight
(Figure 1B) or bladder to body weight ratio (Figure 1C). As
reported previously [32], the body weight was reduced 10 weeks
following tamoxifen treatment (Figure 1D).
Altered Micturition Pattern in the Absence of Smooth
Muscle miRNAs
To test if the loss of miRNAs affected the voiding pattern of
freely moving mice, urine was collected on filter papers that were
subsequently photographed under UV light (Figure 2A). Analysis
of the number of spots demonstrated an increased number of spots
for the KO compared to the control mice (Figure 2B). Mice tend
to void in the corners or along the edge of the cage and this pattern
changes in micturition disturbances [27]. In fact, the increased
micturition frequency was accounted for by the increase in the
centrally localized spots (Figure 2B). To address whether motor
function of the KO detrusor was altered, bladders were fitted with
pressure transducers. Bladder volume was then increased in a step-
wise fashion to 200 ml. In resting bladders the pressure changed
little with filling and no spontaneously generated pressure peaks
were observed. Depolarization (60 mM K
+) resulted in prompt
increases in pressure. The amplitude of this response declined with
increasing volume as expected from the law of Laplace. The
attained pressure on activation with K
+ was lower in KO bladders
at all filling volumes (Figure 2C).
Detrusor Muscle Contractile Function is Impaired in the
Absence of miRNAs
To confirm that the reduced ability of whole bladder
preparations to generate pressure was due to impaired contractility
we mounted strips of bladder smooth muscle in myographs and
generated length-tension relationships. As shown in Figure 3A,
active force in response to depolarization with 60 mM K
+ was
reduced in Dicer KO strips at all muscle lengths. Passive force on
the other hand was not altered (Figure 3B). Stress (force per cross-
sectional area) was reduced at circumferences exceeding 12 mm
Figure 1. Reduced levels of detrusor miRNAs and maintained wet weight in Dicer KO urinary bladder. Highly expressed miRNAs were
selected in an array experiment and analyzed here by qPCR in control (black bars) and Dicer KO (white bars) urinary bladders excised 10 weeks
following tamoxifen treatment (A) (n=6). MiR-451 is generated in Dicer independent manner and was included as a negative control. The bladder
wet weights, bladder to body weight ratios, and body weights of control and Dicer KO bladders is shown in B-D (n=13).
doi:10.1371/journal.pone.0035882.g001
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not changed (Figure 3D), whereas force at L0 was reduced
(Figure 3E). Taken together these findings confirm reduced
contractility in the absence of detrusor miRNAs and additionally
show that this occurs without remodeling.
Altered Responsiveness to Electrical Field Stimulation in
Dicer KO Detrusor Muscle
Electrical field stimulation ex vivo causes release of neurotrans-
mitter substances from autonomic nerves and subsequent muscle
Figure 2. Disturbed micturition pattern and impaired pressure generation in the isolated bladder. Voided urine was collected on filter
papers. Panel A shows filter papers photographed under UV light. Panel B shows summarized data. Panel C shows pressure of isolated and
cannulated bladders during 5 min of stimulation with 60 mM K
+ at different volumes (6–8).
doi:10.1371/journal.pone.0035882.g002
Figure 3. Reduced active stress in Dicer KO detrusor strips. Active (A) and passive (B) length-tension relationships were generated using strips
from control and Dicer KO bladders. The muscle strips were stimulated in 60 mM K
+ and relaxed in nominally calcium-free solution. Stress (C) was
calculated using the length and weight of the individual preparations. The calculated circumference at which the bladder generated maximal active
force (L0) was not different in Dicer KO bladders (D). Stress at L0 is shown in E (n=11).
doi:10.1371/journal.pone.0035882.g003
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35882Figure 4. Deletion of Dicer in smooth muscle impairs the cholinergic component of the neurogenic contraction. Detrusor muscle strips
from control and Dicer KO mice were activated by electrical field stimulation in the absence and presence of scopolamine and after desensitization of
purinergic receptors using a,b-methylene-ATP in the continued presence of scopolamine. Full frequency response curves in control conditions, in the
presence of scopolamine (1 mM), and after desensitization of purinergic receptors using a,b-methylene-ATP (10 mM) in the continued presence of
scopolamine are shown for control and Dicer KO bladders in A and B, respectively, 10 weeks following Tamoxifen treatment. The cholinergic
component of activation (C) was calculated by subtracting the force in the presence of scopolamine from force in control conditions. The purinergic
component of activation (D) was calculated by subtracting residual force (after a,b-methylene-ATP and in the presence of scopolamine) from force in
the presence of scopolamine. The stress (force per cross-sectional area) for the different components was calculated using absolute force values, strip
length, strip weight, and assuming a density of 1.06; the resulting data is shown in E-F. Stress was then calculated for the scopolamine sensitive
(cholinergic, E) and the a,b-methylene-ATP sensitive (purinergic, F) components (n=10).
doi:10.1371/journal.pone.0035882.g004
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control and KO detrusor strips under control conditions, after
inhibition of muscarinic receptors using scopolamine and after
desensitization of purine receptors using a,b-methylene-ATP
(Figure 4A-4D; c.f. Figure S1 for a merged version of 4A and
4B). We plotted the scopolamine-sensitive (cholinergic) and a,b-
methylene-ATP-sensitive (purinergic) components of activation for
control and Dicer KO bladders as stress (Figure 4E and 4F). A
striking reduction of the muscarinic component was seen in Dicer
KO compared to control detrusor. The purinergic component of
activation on the other hand was unchanged. When force was
normalized to K
+ contraction (or maximal nerve-induced
activation) rather than being expressed as stress, the cholinergic
component remained reduced whereas the purinergic component
was increased (Figure 4C and 4D). A similar, albeit less
pronounced, increase of the relative purinergic component was
evident already 5 w post Tamoxifen (Figure S2). Taken together,
a state of ‘‘scopolamine resistance’’ is evident in the Dicer KO
detrusor together with a relative increase of the purinergic
component of neurogenic activation, i.e. changes known to occur
in many pathological bladder disturbances.
Electron Microscopy Analysis of Smooth Muscle Cells in
Dicer KO Bladder
In order to examine if the disturbed contractility was associated
with ultrastructural changes, detrusor smooth muscle was
examined using electron microscopy (Figure 5A-5F). We used
three control and three KO detrusors fixed at identical volumes to
measure cell cross-sectional area, the percentage of the cell
membrane length that was occupied by dense bands, the density of
caveolae, the nerve terminal distances, the size of the synaptic
clefts, and the distance between cells (Figure 5G-5L). Overall, the
ultrastructure was well maintained in KO bladders. Except for an
increase in the distance between smooth muscle cells, all other
parameters remained similar in KO and control bladders
(Figure 5G-5L). Thus, the reduced contractility in response to
nerve activation occurs without a change in the density of neurons
reaching the bladder and without conspicuous changes in the
overall morphology or cross-sectional area of smooth muscle cells.
Phenotypic Modulation of Detrusor Smooth Muscle in
the Absence of miRNAs
In vascular smooth muscle, deletion of Dicer results in a general
reduction of differentiation as characterized by a lower expression
of smooth muscle differentiation markers. To examine if this
occurs in the detrusor upon deletion of Dicer we determined the
expression of calponin, desmin, a-actin, and SM22 by western
blotting (Figure 6A-6E). Clear-cut reductions were seen in
calponin and desmin whereas the levels of a-actin and SM22
were unchanged. Myocardin levels were similarly unchanged
(Figure 6E). Quantitative RT PCR results mirrored the changes at
the protein level and additionally showed a modest reduction of
myosin heavy chain (Myh11) but unchanged SRF expression
(Figure 6F-6J and data not shown). These findings indicate
Figure 5. Electron microscopy reveals normal cell morphology and innervation but increased distance between cells in Dicer KO
urinary bladder. Smooth muscle cells in control (A, C, E) and Dicer KO (B, D, F) bladders were analyzed by electron microscopy. 600 EM micrographs
in total were used for quantitative analysis of the density of caveolae (G), the relative proportion of each cell profile that was occupied by dense
bands (H), the cell cross sectional area (I), the distance between nerve terminals (J), the width of the synaptic cleft at sites with no Schwann cell
coating (K), and the cell to cell distance (L) (n=3–4).
doi:10.1371/journal.pone.0035882.g005
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not readily explain the selective reduction of depolarization-
induced stress (Figure 3) relative to the purinergic component of
nerve-induced stress (Figure 4F).
Response of Dicer KO Detrusor Strips to Exogenous
Agonists
In order to confirm that depolarization-induced contraction is
indeed selectively impaired in the Dicer KO detrusor we
contracted bladder strips with 60 mM K
+. After washout and
relaxation preparations were contracted with exogenous ATP
(3 mM, Figure 7A). As predicted from the results in Figure 3 and
4, the depolarization-induced response was drastically reduced in
comparison to the peak of the subsequent ATP response
(p,0.001). ATP-induced stress on the other hand was un-
changed (Figure 7B). Similar results were obtained for a,b-
methylene-ATP (Figure 7C). We next generated full concentra-
tion-response curves for the muscarinic agonist carbachol. A
modest reduction of stress was seen at saturating concentrations
of carbachol (Figure 7D). However, carbachol contraction was
increased following normalization to K
+ contraction in the same
strip (p,0.01, not shown), contrasting with the cholinergic
neurogenic component. These findings verify a selective re-
duction of depolarization-induced contractility not only relative
to ATP, but also relative to carbachol. In further support of this
specificity we found that direct activation of the contractile
machinery using the phosphatase inhibitor calyculin A resulted in
similar contraction in control and Dicer KO detrusor strips
(70610 vs. 63616 mN/mm
2, n.s.).
Reduced Expression of L-type Ca
2+ Channels in Dicer KO
Detrusor
Genetic ablation of L-type Ca
2+ channels leads to selective
impairment of KCl-induced contraction as compared to
stimulation with carbachol (,90% vs. ,35% inhibition of
tonic phase, [33]). Moreover, P2X1 channels, which are
involved in detrusor activation by ATP, are directly permeable
to Ca
2+ which implies a less critical role of L-type channels in
the ATP response compared to the KCl response. To test the
validity of this concept under our assay conditions we pre-
incubated bladder strips with the L-type Ca
2+-channel blocker
nifedipine (1 mM) and then contracted the strips with either
60 mM KCl or 3 mM ATP. As shown in Figure 8A, nifedipine
inhibited KCl-induced contraction by 9061%; ATP-induced
contraction was inhibited by only 5464% (p,0.001 vs. KCl).
Reduced expression of L-type Ca
2+-channels in Dicer KO
bladder could thus potentially explain the specificity of miRNA
deletion for KCl-induced contraction. We therefore assayed the
level of transcript for the pore-forming subunit of the L-type
Ca
2+-channel (cacna1c) and the level of protein (Cav1.2). Both
Figure 6. Reduced contents of calponin and desmin in Dicer KO detrusor. Expression of the differentiation related proteins calponin (A),
desmin (B), smooth muscle a-actin (C), SM22 (D), and myocardin (E) was analyzed in control (black bars) and Dicer KO (white bars) bladders by
western blotting 10 weeks post tamoxifen treatment. Original blots are shown below the individual bar graphs. HSP90 was used as loading control
throughout (n=6–8). Transcript levels for selected genes were examined in control and Dicer KO detrusor by qPCR 10 weeks post tamoxifen
treatment. Primers for genes encoding calponin (Cnn1, F), Desmin (Des, G), smooth muscle a-actin (Acta2, H), SM22 (Tagln, I), Myocardin (Myocd,J )
were used (n=5–11).
doi:10.1371/journal.pone.0035882.g006
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together, these findings argue that impaired motor function of
the Dicer KO detrusor can be traced back to a reduced
expression of L-type Ca
2+ channels.
Recent work has indicated that cacna1c/Cav1.2 expression is
negatively regulated by CamKIId activity [34,35]. Because
CamKIId is a predicted and validated target for the highly
expressed miR-145 [16], we examined the expression of CamKIId
by western blotting. The CamKIId level tended to be increased in
KO detrusor, but this difference did not reach statistical
significance (Figure 8D).
Discussion
In the present study we used smooth muscle-specific and
Tamoxifen-inducible knockout of Dicer to evaluate the impor-
tance of miRNAs for urinary bladder function in mice. We found
that loss of miRNAs affected the voiding pattern of un-
anaesthetized and freely moving animals and impaired the motor
function of the intact bladder. These effects were associated with
reduced contractile differentiation of the detrusor muscle and
reduced expression of L-type Ca
2+ channels. Our findings also
imply that cholinergic neuro-effector transmission must be affected
at a junctional or pre-junctional level. This is because the
cholinergic component of neural activation was more drastically
affected than the response to exogenous carbachol (reduced and
increased relative to K
+, respectively).
The effect of Dicer KO on detrusor smooth muscle marker
expression is milder than previously reported by us for Dicer-
deficient vascular smooth muscle [26,32]. In vascular smooth
muscle the effects are due in part to miR-145, which regulates
smooth muscle differentiation via multiple mechanisms including
myocardin expression [19], actin polymerization [18,32], and
angiotensin signaling [17]. Accordingly, robust reductions of
smooth muscle a-actin, SM22, calponin and myosin heavy chain
were previously found in Dicer-deficient vascular smooth muscle
[26]. Here we find reductions of calponin and desmin, whereas the
levels of smooth muscle a-actin, SM22 and myocardin were
unchanged. Findings in the literature nonetheless support the idea
that the changes that we observe may contribute to the contractile
deficit. Genetic ablation of smooth muscle calponin, which is an
actin binding protein that regulates actin-myosin interaction [36],
was found to result in a 40% reduction of depolarization-induced
force in aorta and vas deferens [37,38]. Lack of the desmin
similarly resulted in a 50% reduction of depolarization-induced
stress in the urinary bladder [39].
A cause and effect relationship between the reduced levels of
calponin and desmin and the impaired detrusor contractility is
challenged by a number of observations. The first and most
important observation was that Dicer deletion showed marked
specificity for depolarization-induced force. Indeed, carbachol and
ATP-induced contractions were much less affected or largely
unaffected. When the membrane activation step was bypassed
using the potent phosphatase inhibitor Calyculin A, no difference
was observed between control and Dicer KO bladder, arguing for
a largely functional contractile machinery. The ultrastructure of
the smooth muscle moreover appeared normal, with normal cross-
sectional areas of the muscle cells, thin and thick filaments, and no
expansion of rough endoplasmic reticulum; that is, no hallmarks of
the so called synthetic phenotype were evident. Taken together,
this argues for additional effects of Dicer deletion at the level of
membrane excitation.
Detrusor contraction shows a high degree of sensitivity to L-type
Ca
2+ channel blockers [40]. Here, we found that expression of the
pore-forming subunit of the L-type Ca
2+ channel (Cav1.2, Cacna1c)
was reduced by ,50% in Dicer KO detrusor. Work on smooth
muscle-specific Cav1.2 knockout mice demonstrated that lack of
these channels resulted in a ,90% reduction of the tonic KCl
response in detrusor strips. The tonic carbachol response on the
other hand was reduced by only ,35% [33]. Reduced expression
Cav1.2 thus represents a likely reason for the preferential effect of
Dicer deletion on KCl-induced contraction, and our finding that
ATP responses were more resistant to nifedipine than were KCl
responses concurs with this view. Previous work in smooth muscle
has demonstrated reduced expression of L-type Ca
2+ channels in
phenotypically modulated smooth muscle cells [41]. Our own
Figure 7. Selective reduction of depolarization-induced stress
in Dicer KO bladder. Panel A shows original force records of control
(black line) and Dicer KO (gray line) bladder strips. Following
contraction in response to 60 mM K
+ (HK) and relaxation, 3 mM ATP
was added every 10 min. The preparations were washed three times
following each ATP challenge. Insets show representative ATP
responses on an expanded time scale (n=4–7). B and C show
summarized data for the peak ATP- and a,b-methylene-ATP-induced
stress in control (black bar) and Dicer KO (white bar) bladders. Panel D
shows cumulative concentration-response relationship for carbachol for
control and Dicer KO bladders (n=10–11).
doi:10.1371/journal.pone.0035882.g007
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culture reduced L-type Ca
2+ current in a Ca
2+-dependent manner
[42]. Since L-type Ca
2+ channels directly contribute to the
differentiation process [43,44], their reduced expression may
constitute an initial and critical step in the phenotype switch that is
initiated by deletion of miRNAs from smooth muscle. The
differential loss of smooth muscle marker expression in detrusor
versus vascular smooth muscle at 10 weeks following Dicer
deletion may therefore reflect different time-courses of L-type
calcium channel expression in these tissues.
The basis of the reduced expression of L-type Ca
2+ channels in
Dicer KO bladder is not known. Recent work on cardiomyocytes
has shown that overexpression and deletion, respectively, of
CamKIId results in reduced and increased L-type Ca
2+ channel
expression [34,35]. Increased CamKIId expression is moreover
a signature feature of the phenotype switch in vascular smooth
muscle [45], and recent work has identified CamKIId as a direct
target of miR-145 [16]. Upregulation of CamKIId is thus an
appealing candidate mechanism by which L-type Ca
2+ channel
expression drops in Dicer KO bladder. However, we did not
detect a significantly altered expression of CamKIId in the Dicer
KO bladder. We cannot rule out significant changes at earlier time
points, but this finding suggests additional, or completely different,
mechanisms. One possibility is that NFkB, which has been
proposed to play a role for L-type Ca
2+ channel expression in the
vasculature [46], is involved. Additional work is required to test
these possibilities.
The reduced scopolamine-sensitive (cholinergic) component of
activation during electrical field stimulation in Dicer KO bladder
is intriguing. This reduction was significantly more pronounced
than was the reduction of contractility in response to carbachol.
We interpret this to reflect impaired cholinergic neuro-effector
transmission. Electron microscopy did not indicate an altered
density of detrusor nerve terminals or overt changes in the size of
the synaptic clefts, ruling out partial denervation. One remaining
possibility is reduced release of acetylcholine from neural
varicosities. Previous work has demonstrated important roles of
miRNAs in neuronal differentiation and synaptic function [47,48],
but neuronal miRNAs are not targeted in our model so any pre-
junctional effects must be indirect. Putative neuronal changes
could, for example, depend on transfer (or loss thereof) of miRNAs
from smooth muscle to neurons where proteins that play a role in
synthesis and release of acetylcholine are targeted. A primary
deficit in the smooth muscle cells, on the other hand, may involve
Figure 8. Reduced expression of L-type Ca
2+ channels in Dicer KO bladder. Panel A shows contractile responses to 60 mM K
+ and 3 mM
ATP, respectively, before (black trace) and after (gray trace) addition of the L-type Ca
2+ channel blocker nifedipine (1 mM). Both K
+ (not shown) and
ATP (Figure 7A) responses were highly reproducible (n=4). Panels B and C show the mRNA and protein levels for the pore-forming subunit of the L-
type Ca
2+ channel (Cacna1c and Cav1.2) in control (black bars) and Dicer KO (white bars) bladder. Expression of CamKIId is shown in D (n=6–10).
doi:10.1371/journal.pone.0035882.g008
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expression of acetylcholine esterase in the synaptic cleft. Whatever
the case, it must be considered that a neurotransmission defect
may in part be responsible for the reduced KCl responses. This is
because depolarization is expected to cause release of transmitters
and neuropeptides from peripheral nerve endings, including
acetylcholine and neurokinins. Reduced neuronal release might
therefore contribute less to KCl-induced force development in the
KO bladder.
In summary, knockdown of miRNAs in the urinary bladder
affects spontaneous micturition as well as contractile function of
the isolated bladder. This is associated with reduced expression of
contractile marker proteins and L-type Ca
2+ channels. A reduction
of the atropine/scopolamine-sensitive component of neurogenic
activation together with an increased relative purinergic compo-
nent has been reported for bladder instability [8], interstitial
cystitis [9], and normal ageing [10]. The current study thus
provides proof of principle that smooth muscle cells can be
primary culprits in the chain of events that leads to detrusor
instability as defined by the increased spontaneous micturition and
the characteristic changes in neuro-effector transmission and
contractility.
Supporting Information
Figure S1 Combined data on contraction induced by
electrical field stimulation at 10 weeks post tamoxifen.
Data in Figure 4 A and B were merged in one panel to facilitate
direct comparison of WT and KO data.
(TIF)
Figure S2 Effect of Dicer deletion on electrical field
stimulation-induced contraction at 5 weeks. Full frequency
response curves in control conditions, in the presence of
scopolamine (1 mM), and after desensitization of purinergic
receptors using a,b-methylene-ATP (10 mM) in the continued
presence of scopolamine are shown for control and Dicer KO
bladders in A and B, respectively, 5 weeks following Tamoxifen
treatment. The cholinergic component of activation (C) was
calculated by subtracting the force in the presence of scopolamine
from force in control conditions. The purinergic component of
activation (D) was calculated by subtracting residual force (after
a,b-methylene-ATP and in the presence of scopolamine) from
force in the presence of scopolamine. E shows the relative peak
force on addition of a,b-methylene-ATP (n=8–9).
(TIF)
Table S1 MicroRNA (miRNA) qPCR-arrays define high-
ly expressed miRNAs in the detrusor and demonstrate
effective knock down of most miRNAs. QPCR based
miRNA arrays were run on pooled detrusor samples from control
and smooth muscle-specific Dicer KO mice. Fold expression
relative to housekeeping genes is shown in the middle column and
the percentage of knockdown in Dicer KO bladders is shown in
the right column. The expression levels shown are assuming equal
efficiency of the primers. The data are from a single experiment
from six pooled bladders of each genotype.
(TIF)
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